Asenapine
Links shared publicly online about this topic
Lurasidone = Asenapine = Iloperidone | Psydir News
news.psydir.com — “Last week I asked, rhetorically, whether I should waste my time reviewing the published researched on the potential new antipsychotic drug Dainippon (lurasidone). Luckily for me, there isn't much (1a, 1b).Well that's not entirely true. I did come across this study titled,” View full resource at news.psydir.com
Most Recently Shared on September 11, 2009 at 10:37 am By:
Lurasidone = Asenapine = Iloperidone http://ow.ly/15OBOy
Article > Europe approves Merck & Co's asenapine
pharmatimes.com — “Article > Europe approves Merck & Co's asenapine” View full resource at pharmatimes.com
Most Recently Shared on September 6, 2010 at 11:03 am By:
Peter H Brown Doctor and Psychologist
Europe approves Merck & Co's asenapine http://bit.ly/abV9JR #bipolar
Treatment With SAPHRIS® (asenapine) Sublingual Tablets
saphris.com — “SAPHRIS medication is commonly used to treat bipolar I disorder and schizophrenia in adults. Visit SAPHRIS and learn more about common symptoms and treatment.” View full resource at saphris.com
Most Recently Shared on July 15, 2010 at 5:44 pm By:
HealthEd Health Business and Medical Education
We're pleased and proud to announce the launch of http://www.saphris.com
Schering-Plough Announces FDA Approval of Saphris (asenapine)
drugs.com — “Saphris (asenapine) is used to treat schizophrenia and bipolar I disorder. Includes Saphris side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on August 15, 2009 at 6:07 am By:
Schering-Plough Announces FDA Approval of Saphris (asenapine) - http://bit.ly/XvAmd
FDA Approves Saphris Tablets (asenapine) To Treat Schizophrenia And Bipolar Disorder
medicalnewstoday.com — “The U.S. Food and Drug Administration has approved Saphris tablets (asenapine) to treat adults with schizophrenia, a chronic, severe and disabling brain disorder, and to treat bipolar I disorder i” View full resource at medicalnewstoday.com
Most Recently Shared on August 16, 2009 at 12:35 pm By:
psychiatryrounds Support and Psychiatry
FDA Approves Saphris Tablets (asenapine) To Treat Schizophrenia And Bipolar Disorder: The U.S. Food and Drug Adm.. http://bit.ly/ePdzL
Asenapine for schizophrenia and bipolar I disorder — Current Psychiatry Online
currentpsychiatry.com — “Asenapine for schizophrenia and bipolar I disorder — Current Psychiatry Online” View full resource at currentpsychiatry.com
Most Recently Shared on December 18, 2009 at 3:17 pm By:
Current Psychiatry Medical Journal and Psychiatry
Asenapine (Saphris)--new med for schizophrenia & bipolar I--offers unique receptor profile, sublingual delivery http://bit.ly/5BO6G2
FDA Alert: Saphris (asenapine maleate): Drug Safety Communication: Serious Allergic Reactions
drugs.com — “FDA Alert: Saphris (asenapine maleate): Drug Safety Communication: Serious Allergic Reactions” View full resource at drugs.com
Most Recently Shared on September 1, 2011 at 8:27 pm By:
FDA Alert - Drug Safety Communication: Saphris (asenapine maleate) - Serious Allergic Reactions - http://t.co/yQPehSy
FDA Alert: Saphris (asenapine maleate): Drug Safety Communication: Serious Allergic Reactions
drugs.com — “FDA Alert: Saphris (asenapine maleate): Drug Safety Communication: Serious Allergic Reactions” View full resource at drugs.com
Most Recently Shared on September 1, 2011 at 9:04 pm By:
Drugs and Devices OW OW Health
Saphris (asenapine maleate): Drug Safety Communication: Serious Allergic Reactions: Audience: Psychiatry, P... http://t.co/icYEa9b #FDA
Merck Receives Approval from FDA for Expanded Indications for Atypical Antipsychotic Medication Saphris (asenapine) Sublingual Tablets
drugs.com — “Saphris (asenapine) is used for the treatment of schizophrenia and bipolar I disorder. Saphris information includes news, clinical trial results and side effects.” View full resource at drugs.com
Most Recently Shared on September 14, 2010 at 1:14 am By:
Drugs and Devices OW OW Health
Merck Receives Approval from FDA for Expanded Indications for Atypical Antipsychotic Medication Saphris (asen... http://bit.ly/cBfzbG #drug
FDA Drug Safety Communication: Serious allergic reactions reported with the use of Saphris (asenapine maleate)
fda.gov — “[09-01-2011] The U.S. Food and Drug Administration (FDA) is warning the public that serious allergic reactions have been reported with the use of the antipsychotic medication Saphris (asenapine maleate).” View full resource at fda.gov
Most Recently Shared on September 1, 2011 at 6:09 pm By:
SNAPPIN' MINISTRIES Patient Advocate
FDA Drug Safety Communication: Serious allergic reactions reported with use of Saphris (asenapine maleate): http://t.co/ZGivqxI via @AddThis
FDA Drug Safety Podcast for Healthcare Professionals: Serious allergic reactions reported with the use of Saphris (asenapine maleate)
fda.gov — “FDA Drug Safety Podcast for Healthcare Professionals: Serious allergic reactions reported with the use of Saphris (asenapine maleate)” View full resource at fda.gov
Most Recently Shared on September 2, 2011 at 2:57 pm By:
RT @fda_drug_info: Drug Safety Podcast:Serious allergic reactions reported with the use of Saphris. http://t.co/AKdbvNt
New Antipsychotic Drug Asenapine (Saphris) Helps Prevent Relapse In People With Schizophrenia; Phase III Data Presented At ECNP
medicalnewstoday.com — “Schizophrenia is a difficult condition for patients and their families to manage. relapse is a frequent occurrence, particularly if patients decide to discontinue antipsychotic drug treatment beca” View full resource at medicalnewstoday.com
Most Recently Shared on September 18, 2009 at 7:10 pm By:
psychiatryrounds Support and Psychiatry
New Antipsychotic Drug Asenapine (Saphris) Helps Prevent Relapse In People With Schizophrenia; Phase III Data Pr.. http://bit.ly/SYW4n
News - Asenapine as Effective as Olanzapine for Long-Term Treatment of Patients With Bipolar Disorder: Presented at EPA
docguide.com — “Asenapine as Effective as Olanzapine for Long-Term Treatment of Patients With Bipolar Disorder: Pres” View full resource at docguide.com
Most Recently Shared on March 4, 2010 at 2:16 am By:
Peter H Brown Doctor and Psychologist
Asenapine as Effective as Olanzapine for Long-Term Treatment of Patients With ... http://bit.ly/d4IaPv #bipolar
FDA Approves Saphris Tablets (asenapine) To Treat Schizophrenia And Bipolar Disorder | Psydir News
news.psydir.com — “The U.S. Food and Drug Administration has approved Saphris tablets (asenapine) to treat adults with schizophrenia, a chronic, severe and disabling brain disorder, and to treat bipolar I disorder in adults, a serious psychiatric disorder that causes shifts in a person's mood, energy, and ability to function.” View full resource at news.psydir.com
Most Recently Shared on August 16, 2009 at 12:31 pm By:
FDA Approves Saphris Tablets (asenapine) To Treat Schizophrenia And Bipolar Disorder http://ow.ly/15Ldfh
FDA Approves Asenapine Sublingual Tablets for Expanded Use in Schizophrenia, Bipolar Disorder - QualityPoint Technologies
qualitypointtech.net — “Merck announces FDA approval for expanded adult use of its asenapine sublingual tablets to now include maintenance treatment for schizophrenia and as adjunctive therapy for bipolar 1 disorder. Medscape Medical News” View full resource at qualitypointtech.net
Most Recently Shared on September 14, 2010 at 9:36 pm By:
FDA Approves Asenapine Sublingual Tablets for Expanded Use in Schizophrenia, Bipolar Disorder: Merck announces FDA... http://bit.ly/9V6vFU
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Featuring the top 3 experts for this topic
-
PsyDir News
Best psychology and psychotherapy news
-
Peter H Brown
Peter H Brown Clinical Psychologist. I'm also a Husband & Dad & wannabe techno-junkie
-
HealthEd
Tweets from Jeff Greene & Charlie Tarzian of HealthEd, a specialized agency that uses education to achieve better health outcomes
Advertisement
